Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.
Nordström, Dan
Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study. [electronic resource] - The Journal of rheumatology Oct 2012 - 2008-11 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1499-2752
10.3899/jrheum.111549 doi
Adult
Antirheumatic Agents--therapeutic use
Azathioprine--therapeutic use
Female
Humans
Interleukin 1 Receptor Antagonist Protein--therapeutic use
Isoxazoles--therapeutic use
Leflunomide
Male
Methotrexate--therapeutic use
Middle Aged
Receptors, Interleukin-1--antagonists & inhibitors
Remission Induction
Still's Disease, Adult-Onset--drug therapy
Sulfasalazine--therapeutic use
Treatment Outcome
Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study. [electronic resource] - The Journal of rheumatology Oct 2012 - 2008-11 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1499-2752
10.3899/jrheum.111549 doi
Adult
Antirheumatic Agents--therapeutic use
Azathioprine--therapeutic use
Female
Humans
Interleukin 1 Receptor Antagonist Protein--therapeutic use
Isoxazoles--therapeutic use
Leflunomide
Male
Methotrexate--therapeutic use
Middle Aged
Receptors, Interleukin-1--antagonists & inhibitors
Remission Induction
Still's Disease, Adult-Onset--drug therapy
Sulfasalazine--therapeutic use
Treatment Outcome